Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

London pre-open: Stocks seen down as investors mull borrowing data

(Sharecast News) - London stocks were set to fall at the open on Tuesday following a downbeat Asian session, as investors mulled the latest UK borrowing figures. The FTSE 100 was called to open 10 points lower at 8,004.

Data out earlier from the Office for National Statistics showed that the budget surplus narrowed sharply in January.

The Treasury recorded a surplus of £5.4bn borrowing, versus expectations for a £7.8bn deficit. This was down £7.1bn compared to January 2022.

The data showed that self-assessed income tax receipts hit a record of £21.9bn - the highest January figure since monthly records began in April 1999 and up £5.5bn on January 2022.

Capital Economics said: "January's public finances figures suggest the Chancellor may have scope for some giveaways in his Budget on 15th March.

"But with the OBR poised to slash its medium-term economic growth forecasts, any hopes the Chancellor might be able to give away a significant amount of money, while sticking to his previous debt-reduction plans, may be disappointed."

Still to come, UK services and manufacturing PMIs for February are due at 0930 GMT.

In corporate news, HSBC said quarterly profits almost doubled, driven by the rise in global interest rates, and unveiled a special dividend.

The Asia-focused bank reported pretax earnings of $5.2bn, up from $2.7bn and ahead of the $4.96bn company-compiled average.

Annual expected credit losses rose to $3.6bn, more than forecasts of $3.2bn, due to rising inflation and China's struggling property market.

Full-year profit fell to $17.5bn from $18.9bn, largely down to a $2.4bn charge on the sale of its retail banking operations in France.

Elsewhere, Smith & Nephew reported full-year revenue of $5.22bn (£4.35bn), showing a 4.7% increase on an underlying basis, but only 0.1% reported growth due to currency headwinds.

The FTSE 100 medical device firm's trading profit was $901m, with a margin of 17.3% as a result of higher inflation. Cash generated from operations was $581m, and the company completed $150m of its share buyback programme. The full-year dividend remained unchanged at 37.5 US cents per share.

Share this article

Related Sharecast Articles

London open: Stocks gain as investors mull Rightmove data; inflation eyed
(Sharecast News) - London stocks edged higher early trade on Monday as investors mulled the latest UK house price figures and looked ahead to key inflation data later in the week.
London pre-open: Stocks seen up as investors mull Rightmove data
(Sharecast News) - London stocks were set to rise at the open on Monday as investors mulled the latest UK house price figures.
London close: Stocks recoup some earlier losses
(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.
London midday: FTSE stays down; Auto Trader hit by downgrade
(Sharecast News) - London stocks were still in the red by midday on Friday, having taken their opening cue from a downbeat close on Wall Street.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.